JANICZEK WEALTH MANAGEMENT, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
JANICZEK WEALTH MANAGEMENT, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$1,726
-26.4%
4050.0%0.00%
-100.0%
Q4 2022$2,345
+17.2%
4050.0%0.00%0.0%
Q3 2022$2,000
-33.3%
4050.0%0.00%0.0%
Q2 2022$3,000
+200.0%
405
+113.2%
0.00%–
Q1 2022$1,000–1900.0%0.00%–
Q4 2021$0–190–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders